SF3B1 and myelodysplastic syndrome: Furthermore, the fact that SF3B1-mutated stem cells constitute a ‘pre-leukaemic' reservoir for more destabilizing mutations to occur points to the need of further large in vivo studies to identify, monitor and develop effective therapeutic strategies to prevent further subclonal evolution, recurrence and disease progression observed in MDS-RS patients.